Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer.
Spigel DR, Dowlati A, Chen Y, Navarro A, Yang JC, Stojanovic G, Jove M, Rich P, Andric ZG, Wu YL, Rudin CM, Chen H, Zhang L, Yeung S, Benzaghou F, Paz-Ares L, Bunn PA; RESILIENT Trial Investigators. Spigel DR, et al. J Clin Oncol. 2024 Apr 22:JCO2302110. doi: 10.1200/JCO.23.02110. Online ahead of print. J Clin Oncol. 2024. PMID: 38648575
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.
Borghaei H, de Marinis F, Dumoulin D, Reynolds C, Theelen WSME, Percent I, Gutierrez Calderon V, Johnson ML, Madroszyk-Flandin A, Garon EB, He K, Planchard D, Reck M, Popat S, Herbst RS, Leal TA, Shazer RL, Yan X, Harrigan R, Peters S; SAPPHIRE Investigators. Borghaei H, et al. Ann Oncol. 2024 Jan;35(1):66-76. doi: 10.1016/j.annonc.2023.10.004. Epub 2023 Oct 20. Ann Oncol. 2024. PMID: 37866811 Clinical Trial.
Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29).
Renaud E, Ricordel C, Corre R, Leveiller G, Gadby F, Babey H, Annic J, Lucia F, Bourbonne V, Robinet G, Descourt R, Orione C, Quéré G, Geier M. Renaud E, et al. Among authors: quere g. Transl Lung Cancer Res. 2023 Feb 28;12(2):266-276. doi: 10.21037/tlcr-22-556. Epub 2023 Feb 23. Transl Lung Cancer Res. 2023. PMID: 36895931 Free PMC article.
Model-Augmented Haptic Telemanipulation: Concept, Retrospective Overview, and Current Use Cases.
Hulin T, Panzirsch M, Singh H, Coelho A, Balachandran R, Pereira A, Weber BM, Bechtel N, Riecke C, Brunner B, Lii NY, Klodmann J, Hellings A, Hagmann K, Quere G, Bauer AS, Sierotowicz M, Lampariello R, Vogel J, Dietrich A, Leidner D, Ott C, Hirzinger G, Albu-Schäffer A. Hulin T, et al. Among authors: quere g. Front Robot AI. 2021 Jun 11;8:611251. doi: 10.3389/frobt.2021.611251. eCollection 2021. Front Robot AI. 2021. PMID: 34179105 Free PMC article.
Thyroid dysfunction induced by immune checkpoint inhibitors is associated with a better progression-free survival and overall survival in non-small cell lung cancer: an original cohort study.
Thuillier P, Joly C, Alavi Z, Crouzeix G, Descourt R, Quere G, Kerlan V, Roudaut N. Thuillier P, et al. Among authors: quere g. Cancer Immunol Immunother. 2021 Jul;70(7):2023-2033. doi: 10.1007/s00262-020-02802-6. Epub 2021 Jan 9. Cancer Immunol Immunother. 2021. PMID: 33423089 Free PMC article.
50 results